Likely active: new fund May 2024 Verified 5 Nov 2026
11.2 Capital
Venture firm operating as Cannage Capital, investing across the AI stack from semiconductors to software infrastructure and applications.
- Type
- VC firm
- Location
- Las Vegas, Nevada, United States
- Backs
- Biotech and pharma, B2B software
- Sectors
- Biotech, Healthtech and life sciences, AI, Cybersecurity, Edtech, Semiconductors, Devtools
- Fund size / AUM
- $150M 11.2 Capital III (Form D offering, 2022); $20.1M gross private fund assets (Form ADV; private funds: 1, of which venture capital: 1)
- Latest fund or filing
- 15 May 2025
- Portfolio mix
- Biotech and pharma 50%; B2B software 38%; Hardware 12% (n=8)
- Website
- www.cannagecap.com
Contacts on file
For 11.2 Capital, the paid file holds: 3 named decision-makers with roles.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
GinkgobioworksGetcruiseHingehealthCovariantSardine
Sources
- www.sec.gov/Archives/edgar/data/2022408/000202240825000001/
- adviserinfo.sec.gov/firm/summary/332679
- www.cannagecap.com/
- www.sec.gov/Archives/edgar/data/1955908/000195590823000001/
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 19 lists
Venture capital firms in Las Vegas (16)Venture capital firms in Nevada (28)Semiconductor venture capital firms in the US (42)Semiconductor investors (58)Edtech venture capital firms in the US (83)Edtech investors (153)Developer tools venture capital firms in the US (177)Cybersecurity venture capital firms in the US (214)Developer tools investors (216)Biotech venture capital firms in the US (297)Cybersecurity investors (316)Biotech investors (484)Healthtech venture capital firms in the US (709)SaaS venture capital firms in the US (1,049)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)AI investors (1,576)Venture capital firms in the US (2,975)